The Evidence-based Practice Center Program at the Agency for Healthcare Research and Quality (AHRQ) has posted the draft report for the systematic review on Management of Primary Headaches in Pregnancy. Read more.
The Evidence-based Practice Center Program at the Agency for Healthcare Research and Quality (AHRQ) has posted the draft report for the systematic review on Management of Primary Headaches in Pregnancy. Read more.
Researchers suggest the possibility of an underpinning biological relationship between people with persistent headache and back pain, which could be a target for treatment.
Study Description: Brief Summary: This is a United States Department of Defense funded Focused Program study that aims to identify mechanisms and predictors for persistent of post-traumatic headache attributed to mild traumatic brain injury, and identify methods of preventing post-traumatic headache persistence. The objective of the clinical trial component of the Focused Program is to determine whether intervention with erenumab is an effective treatment for PTH attributed to mTBI.
AbstractObjective: To report a case of petrous apicitis that manifested as chronic migraine without aura and to discuss the pathophysiological mechanisms behind this presentation. Background:Petrous apicitis is a rare complication of acute otitis media with varied clinical presentations that stem from the close proximity of the petrous apex to numerous neurovascular structures. Headache is among the common symptoms of petrous apicitis.
Eli Lilly and Company announced today that the U.S. Food and Drug Administration (FDA) has approved Emgality® (galcanezumab-gnlm) injection (300 mg) for the treatment of episodic cluster headache in adults.
Bring awareness and recognition of headache disorder as a legitimate neurobiological disease and help make individuals with headache disorder know that there are new treatments available. Read about the AAPM Foundation’s Migraine Consensus Guideline project and join AAPM’s Headache and Orofacial Pain Medicine Shared Interest Group.
In honor of National Migraine & Headache Awareness Month, the following related on-demand educational sessions, which were originally presented in conjunction with the AAPM 2018 and 2019 Annual Meeting, can be viewed for free in the AAPM Education Center during the month of June:
Individuals with versus without cluster headache were found to have lower cranial and extracranial pressure pain thresholds, indicating central sensitization, according to a study published in Pain Medicine.
Despite the availability of therapies, many headache syndromes remain refractory to symptomatic treatment, achieving incomplete resolution of pain, and patients with chronic headaches often pursue nonpharmacologic treatments in hopes of achieving a greater duration of pain relief.
Multiple cranial nerve blocks of the greater and lesser occipital, supraorbital, supratrochlear and auriculotemporal nerves are widely used in the treatment of primary headaches. We present efficacy and safety data for these procedures. In an uncontrolled open-label prospective study, 119 patients with chronic cluster headache, chronic migraine, short lasting unilateral neuralgiform attack disorders, new daily persistent headaches, hemicrania continua and chronic paroxysmal hemicrania were examined.
The Agency for Healthcare Research and Quality (AHRQ) has posted key questions for the systematic review on Management of Primary Headaches in Pregnancy for comment through April 11, as well as a draft technical brief on the Treatment for Acute Pain for feedback through April 25. AAPM’s Headache and Orofacial Pain Medicine SIG and Acute Pain Medicine SIG are discussing possible Academy comments. AAPM members are encouraged to consider commenting as individuals.